Daily Archives: November 1, 2022

IGC Reports Financial Results for Second Fiscal Quarter Ended Sept. 30, 2022

POTOMAC, Md.–(BUSINESS WIRE)–India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today reported its second fiscal quarter 2023 financial results. Second Fiscal Quarter 2023 Highlights: IGC-AD1 and TGR-63,…

Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”),…

New Leafly Report: Cannabis is America’s 6th Most Valuable Crop in 2022

SEATTLE–(BUSINESS WIRE)–Leafly Holdings, Inc. (“Leafly”), a leading online cannabis discovery marketplace and resource for cannabis consumers, released today its Cannabis Harvest Report, an unparalleled analysis of the last year of…

PAX Unveils All New Lineup for Cannabis Flower and Concentrate Vaporization

SAN FRANCISCO–(BUSINESS WIRE)–PAX today announced the launch of its new lineup of dry herb vaporizer devices, PAX Mini and PAX Plus, and new PAX Infused Flower with Solventless Hash, for…

Fluence Launches SHYFT Light Scheduler with Best-in-Class Photoacclimation Technology, Empowering Cultivators to Control Lighting Conditions

AUSTIN, Texas–(BUSINESS WIRE)–Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced today the launch of SHYFT Light Scheduler (SHYFT), a lighting automation…

Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors

SAN FRANCISCO–(BUSINESS WIRE)–Teon Therapeutics (Teon), a clinical-stage biopharmaceutical company targeting metabolic signaling pathways and pioneering the development of G-Protein Coupled Receptor (GPCR) immuno-oncology therapies in difficult-to-treat cancers, today announced that…

Applied UV Announces New Debt Financings of $7.5 Million in Aggregate to Support Growth

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas…

Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

WILMINGTON, Del.–(BUSINESS WIRE)–Noramco, LLC, a leading North American producer of controlled substance and specialty bulk Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, today announced it has reactivated its previously…

Receptor Life Sciences Opens Second Investigational New Drug (IND) Application with FDA for RLS103 (Inhaled Dry Powder CBD) for the Treatment of Rapid Epileptic Seizure Termination (REST)

SEATTLE–(BUSINESS WIRE)–Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, is expanding the potential clinical utility of RLS103 into epilepsy. A proof-of-concept clinical…

Columbia Care to Report Third Quarter 2022 Results on November 14, 2022

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the third…